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Abstract
Introduction: Progression of renal failure leads to an increase in the number of patients who require forming 
dialysis access. Old age and rising morbidity make it impossible to form a native arteriovenous fistula and 
a permanent catheter becomes the first choice. The presence of a catheter frequently generates complications, 
including infections, which may result in a higher mortality rate. 
Material and methods: A retrospective analysis data has been conducted, involving 398 patients who had 
permanent catheters implanted from 2010 to 2016. Out of this group, 65 patients who suffered infection-
related complications have been identified. Risk factors for infection and a survival rate of the population have 
been estimated.
Results: Between 2010 and 2016, 495 catheters were implanted for 398 patients aged 68.73 (13.26) 
years on average. 92 catheter-related infections (23.1%) were recorded in 65 patients. Multivariate logistic 
regression showed, that the risk factors of infectious complications were: younger age (P = 0.000), coronary 
artery disease (P = 0.006) and heart failure (P = 0.000). Mortality in the mean 1.38 ± 1.17 years follow-
up period was comparable in infectious and non-infectious subgroups (53.85% vs 49.25%; P = 0.588). 
A higher risk of death in the infectious population was associated with the presence of additional intravas-
cular and intracardiac implanted materials (P = 0.027) and a severe course of infection with hypotension 
(P = 0.027), thrombocytopenia (P = 0.029) and a high leucocytes/platelets ratio (0.017).
Conclusion: Infectious complications in patients dialyzed with permanent catheters are dangerous especially in 
patients with severe clinical course. The mortality rate is high, although similar to all dialyzed by permanent catheters.
Key words: end-stage renal disease, permanent dialysis catheter, infectious complications,  
death risk
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Introduction
The end-stage renal disease leads to an increasing num-
ber of patients who require dialysis therapy and kidney 
transplant. In Poland, approximately 4.5 million people 
suffer from chronic kidney disease and 21,043 patients 
receive renal replacement therapy [1, 2]. Aging of the 
population and high morbidity of this group of patients 
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makes it difficult to create a native arteriovenous fistula, 
still called the gold standard of vascular access. Dialysis 
often starts with a permanent catheter inserted into the 
venous system and its long-term use is limited by a high 
risk of infection and death [2, 3]. Dialysis patients are 
a group particularly vulnerable to infections, mostly those 
spreading through the bloodstream. This exposure is 
largely associated with the presence of infection entry via 
vascular access to dialysis. In addition, the development 
of end-stage renal disease (ESRD) is more common in 
patients with comorbidities: diabetes, hypertension, 
atherosclerosis. The course of uremia leads to further 
dysfunction of many organs and systems. Dialysis treat-
ment makes it possible to remove uremic toxins and to 
balance water and electrolytes, but not completely. This 
results in permanent suppression of the immune system 
with greater exposure to infectious complications.
Infectious complications are one of the most com-
mon reasons for the loss of catheter function. Infections 
related to vascular access account for 50–80% of all 
infections that occur in this patient group, and they lead 
to the death of 10% of dialyzed patients [1, 4].
The aim of this study was to identify risk factors of 
infection-related complications and death risk in a group 
of patients who were dialyzed through permanent 
catheters over a period of seven years’ observation.
Material and methods
The information obtained from the National Health 
Fund (NFZ) provided clinical data for a retrospective 
analysis of 398 patients from the Świętokrzyskie Prov-
ince who had their first permanent catheter inserted 
from 1 January 2010 to 31 December 2016. Out of this 
group, 65 patients who suffered 92 infection-related 
complications were identified, and risk factors for infec-
tion and death of these patients were estimated. The 
study considered impact of the following clinical factors 
on infection-related complications: arterial hyperten-
sion, coronary disease, atrial fibrillation, heart failure, 
generalized atherosclerosis, diabetes, history of stroke, 
neoplastic disease, chronic obstructive pulmonary dis-
ease, presence of cardiac implants (cardiac implantable 
electronic device-CIED, artificial valves, biomaterials 
for vascular prosthetic devices implanted in aorta and 
peripheral vessels), and venous thrombosis. 
Catheter-related infections were diagnosed ac-
cording to the criteria worked out by American and 
European Centres of Prevention and Disease Control 
(HAI: Healthcare Associated Infection, CDC: Centers 
for Disease Control and Prevention; ECDC: European 
Centers for Disease Control and Prevention) [5, 6, 7]. 
Infectious complications were divided into infections of 
a catheter insertion site, infection of a catheter tunnel, 
bacteraemia accompanied by high temperature, shaking 
chills, hypotension and rising inflammatory parameters. 
Catheter Related Bloodstream Infection (CRBSI) was 
defined as an infection of the vascular bed occurred 
within 48 hours from inserting or removing a catheter 
with positive blood culture and isolating the same 
microorganism from peripheral blood and from pus 
from the catheter insertion site. Growth in quantitative 
culture from a catheter tip must be > 10³CFU/ml and 
the number of CFU microorganisms should be five 
times as high as peripheral blood. Detection time of 
samples taken in an automatic system exceeds 2 hours 
and a sample taken from a catheter is marked positive 
earlier than is the case for a sample of peripheral blood. 
Central Line-Associated Bloodstream Infection 
(CLABSI) was defined as an infection in a patient with 
a central catheter when blood culture is positive while 
catheter site culture is negative [5, 7–9].
Based on the analysis of available medical records 
of 47 patients out of 65 subjects with infectious com-
plications, a precise assessment of the influence of 
procedural factors on the development of infection was 
performed. For this group of 47 patients the following 
data were also analysed: reasons for catheter insertion 
and removal, reasons for subsequent hospitalizations 
after its insertion, a number of catheters implanted 
for one person, total and average functioning time of 
one catheter and the functioning times of the catheter 
inserted after a dialysis fistula, time from catheter 
insertion to the onset infection, location of venous 
access and location of a catheter tip. A detailed analysis 
of the following data was also carried out: a course of 
infection-related complications, including the time of 
hospitalization, the occurrence of septicaemia, infec-
tive endocarditis, pneumonia, abscesses distant from 
vascular access site, kind of infection-inducing bacteria 
based on blood and catheter tip cultures as well as 
recurrence of infection. The analysis also involved 
values of biochemical tests and the impact of individual 
factors on a survival rate among patients affected by 
infection-related complications. 
The study was approved by the Bioethics Com-
mittee of Świętokrzyska Medical Council: Resolution 
No 21/2017. 
Statistical methods
Distribution of all continuous variables was evaluated 
by the Shapiro-Wilk test. The continuous data were 
presented as mean with the standard deviation. Cat-
egorical data are presented as absolute numbers and 
percentage. Continuous variables were compared by 
Student’s t-test and Mann-Whitney U test, while chi-
square test with Yates correction was used to compare 
dichotomous variables. 
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Uni- and multivariable linear regression was used to 
determine risk factors of catheter infection 
Only variables with a value of P £ 0.05 at univariate 
analysis were included in the multivariate analysis.
Cumulative survival curves for all-cause death were 
constructed by the Kaplan-Meier methods. Survival 
curves were compared among groups with the log-
rank test. 
The differences were found as statistically significant 
when p < 0.05. 
Results
In the period from January 2010 to December 2016, 
495 permanent catheters were implanted in 398 people 
(194 men,48.7%) with a mean age of 68.73 (13.26) 
years. In the whole study group (n = 398) there were 
92 (23.1%) catheter-related infectious complications 
in 65 (16.3%) patients. In 28 (6.1%) patients repeated 
infections were observed. 
More frequent infectious complications have been 
observed in patients with a longer dwell time of cathe-
ter(s) who needed catheter replacement, patients with 
thrombotic complications including stroke, generalized 
atherosclerosis, diabetes, arterial hypertension, chronic 
atrial fibrillation, coronary artery disease, heart failure, 
history of neoplastic disease and other comorbidities. 
During the mean 1.38 (1.17) years (min 0.0 max 6.70 
years) follow-up 199 deaths occurred (50.0%). There 
was no significant difference in survival between pa-
tients with infectious complications (35, 53.85%) and 
those without infectious complications (164, 49.25%) 
(Table 1).
The univariable analysis demonstrated that gener-
alized atherosclerosis, diabetes, thrombotic catheter 
complications, neoplastic disease, atrial fibrillation, 
arterial hypertension, coronary artery disease, previous 
stroke, heart failure and co-existing diseases were risk 
factors of a catheter-related infection (CRI) (Table 2). 
In the studied group of 398 people, there were 92 
catheter related infectious complications in 65 patients. 
The mean infection rate was 0.46 per 1,000 catheter days.
A detailed analysis of medical records of the sep-
arate subgroup of 47 patients with catheter related 
infectious complications identified 68 infections (13 pa- 
tients suffered from repeated infections). The total 
functioning time of all catheters from insertion of the 
catheter to infection was 13,074 days, the time of the 
longest functioning catheter in this group was 1,108 
days. The total time of hospitalization due to infectious 
complications for the group (n = 47) was 798 days, 
the average time of hospitalization was 11.73 days. 
61 hospitalized patients were treated successfully and 
discharged from the hospital while 7 patients died. 
In the analyzed subgroup of 47 patients with infec-
tious complications, 8 patients (11.76%) developed 
pneumonia and 3 (4.41%) had endocarditis. In 13 
(19.11%) cases, the infection required the removal of 
a permanent catheter.
A comparison of the location of the catheter tip in 
the superior vena cava and the inferior vena cava did 
not show an effect of the catheter placement on the 
incidence of infection (p = 0.68). Similarly, the dura-
tion of catheter functioning had no effect on the risk 
of infection in this group (P = 0.621). A comparison 
of the position of the catheter tip in the superior vena 
cava and the inferior vena cava did not show an effect 
of the position of the catheter on the occurrence of 
infection (P = 0.68).
A detailed analysis of blood culture and catheter 
tip culture identified 42 (61.77%) cases of CRBSI, 22 
(32.35%) cases of bacteraemia with a negative blood 
culture and catheter culture qualified as CLABSI, and 
4 cases (5.88%) of local infection that required hospi-
talization, with a negative blood and catheter cultures, 
and those were mainly abscesses. Infection symptoms 
in a catheter insertion site were found in 25 (37.64%) 
cases, in 16 (23.53%) cases infection occurred together 
with implications of distant organs, including 8 (11.76%) 
cases of pneumonia, 3 (4.41%) cases of infective endo-
carditis and 5 (7.35%) cases of distant skin infections. In 
13 (19.11%) cases, the infection required the removal 
of a permanent catheter.
Infection lesions in catheter insertion site (25 cases) 
co-existed in 18 cases with CRBSI, in 6 cases with 
CLABSI (with negative catheter cultures), and in 1 case, 
a positive catheter culture was not accompanied by 
general symptoms: it was an infection of the skin and 
a catheter tunnel only. 
The study identified 68 infections in 47 dialysed 
patients; 39 (57.35%) cases were caused by Gram-
positive bacteria, and 29 (42.64%) by Gram-negative 
bacteria. Gram-positive infections were caused 
in 20 (29.41%) by Staphylococcus aureus, and in 
19 (27.94%) cases by other staphylococci, mainly 
by Staphylococcus epidermidis. The most common 
Gram-negative pathogens were Klebsiella pneumoniae 
revealed in 8 (11.76%) cases and Escherichia coli in 
8 (11.76%) cases. Summary of pathogens and their 
effect on the course of infection associated with the 
catheter in 68 infectious complications are shown 
in the (Table 4). 
A detailed analysis of survival among 47 patients 
with infection-related complications showed a higher 
death risk among patients with cardiac implantable 
electronic devices (CIED) and biomaterials implanted 
in peripheral vessels. A worse prognosis was identi-
fied among patients with infection accompanied by 
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Table 1. Clinical data of patients dialyzed by permanent catheter and comparison of subgroups with and without catheter-related 
infections
Patients with  
permanent  
catheters
Patients with  
catheter-related  
infection 
Patients without  
infective  
complications 
P 
Mann-Withney  
“U”/c2 test
Number (n, %) 398 (100.0%) 65 (100.0%) 333 (100.0%)
Age [years] mean ± SD 68.73 (13.26) 66.04 (13.20) 69.26 (13.23) P = 0.073
Male (n, %) 194 (48.74%) 36 (55.38%) 158 (47.45%) P = 0.301
No of catheters inserted after 
failure of previously created 
dialysis fistula (n, %)
129 (32.41%) 26 (40.00%) 103 (30.93%) P = 0.199
Dwell times of dialysis 
catheter(s) [days] mean ± SD
505.2 (428.3) 548.3 (449.0) 496.7 (424.3) P = 0.347
Average time of catheter  
usability (days; SD)
435.7 (398.2) 419.4 (392.1) 438.9 (399.9) P = 0.718
No of patients with single  
catheter (n, %)
322 (80.90%) 41 (63.08%) 281 (84.38%) P = 0.0001
No of patients with one  
catheter replacement (n, %)
58 (14.57%) 15 (23.08%) 43 (12.91%) P = 0.053
No of patients with two  
catheter replacements (n, %)
16 (4.02%) 8 (12.31%) 8 (2.40%) P = 0.0007
Venous thrombotic  
complications (n, %)a
66 (16.58%) 18 (27.69%) 48 (14.41%) P = 0.014
Generalized atherosclerosis 
(n, %)b
108 (27.14%) 33 (50.77%) 75 (22.52%) P = 0.000
Diabetes (n, %) 73 (18.34%) 21 (32.31%) 52 (15.62%) P = 0.003
Arterial hypertension (n, %) 109 (27.39%) 35 (53.85%) 74 (22.22%) P = 0.000
Coronary disease (n, %) 44 (11.06%) 22 (33.85%) 22 (6.61%) P = 0.000
Atrial fibrillation (n, %) 12 (3.02%) 7 (10.77%) 5 (1.50%) P = 0.000
Heart failure (n, %) 78 (19.60%) 37 (56.92%) 41 (12.31%) P = 0.000
Past history of stroke (n, %) 4 (1.01%) 3 (4.62%) 1 (0.30%) P = 0.012
History of neoplastic disease  
(n, %)
78 (19.60%) 21 (32.31%) 57 (17.12%) P < 0.008
Co-existing diseases (n, %)c 87 (21.86%) 22 (33.85%) 65 (19.52%) P < 0.017
Death during follow-up (n, %) 199 (50%) 35 (53,85) 164 (49,25%) P = 0.588
No: number; SD: standard deviation; av: average; NS: no statistically significant difference. 
ahistory of venous thromboembolism 
batherosclerosis diagnosed at least in two locations
cco-existing diseases affecting the patients studied, not analysed individually, marked with the following codes the International Statistical Classification of Diseases and 
Related Health Problems — ICD-10: D 50; D53; D64; E03; E04 E27; G65 J20; J42; J44; J45; J 81; J 96; K26; K50; K65; K76; L08; L97; M06; M 32; M 34; S68
hypotension, high leucocytosis, a lower level of blood 
platelets and a high leucocytes/blood platelets (WBC/ 
/PLT) ratio. Present study showed that a type of 
bacteria Gram (+) or Gram (–) had no effect of the 
higher death risk (Table 5). 
Univariable regression analysis shown that the 
following factors contributed to higher risk of death: 
presence of cardiac implants and a severe course of 
infection with hypotension, high leucocytosis, throm-
bocytopenia and a high WBC/PLT ratio (Table 6). 
Discussion
Permanent catheters are an option for patients 
requiring hemodialysis for whom the formation of 
a fistula from own vessels is impossible or contraindi-
cated. Dialysis through a tunnelled catheter may lead to 
numerous dangerous consequences. Catheter-related 
infection occur 41% more frequently than is the case 
among patients with native A-V fistula [10–12]. Ac-
cording to National Kidney Foundation patients with 
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a catheter run the twice as high risk as those using A-V 
fistula [5, 8], and the BSI (bloodstream infection) rate is 
4.85 times as high when tunnelled catheters are used [11]. 
The present study identified 92 (23.1%) catheter-
related infection of an average infection rate of 0.46 per 
1,000 catheter days. In case of tunnelled catheters, ac-
cording to various sources, the frequency of infectious 
complications ranges from 0.5 to 5.5 per 1,000 catheter 
days [11–15]. The large discrepancy of results is prob-
ably related to the diversity of the studied populations 
and the research methodology. Long-term observation 
of a large group of patients in whom 2,230 permanent 
catheters were implanted during 23 years showed 226 
infectious complications, with an infection rate of 0.514 
per 1000 catheter days [16]. In another study, which 
analysed various types of vascular access over 6 years, 
the infection rate for permanent catheters was 1.03 
per 1,000 patient days [11]. The next investigation, 
assessed the impact of the availability of specialist ne-
phrological care on the risk of infection demonstrated 
0.19 infections per 1000 catheter days [15]. According 
to a systematic overview of 200 prospective studies, 
an average BSI rate for tunnelled catheters amounted 
to 1.6 per 1,000 catheter days [17], while in the latest 
reports of 2019, this rate was estimated at 2.26 per 
1,000 catheter days [13]. 
The present study showed that catheter-related 
infection occurred more often in a younger age and 
in patients with coronary artery disease and heart 
failure. One study comparing the risk of infection 
in younger patients (18–74 years old) dialyzed by 
a permanent catheter with a group of elderly patients 
(over 75 years) also demonstrated a higher infection 
risk among the younger patients (1.95 per 1,000 
catheter days) than the older ones (0.55 per 1,000 
catheter days) [18]. Other data regarding the impact 
of various factors on the occurrence of catheter-
related infections are not uniform due to the variety 
of parameters assessed. Most often the effect of 
diabetes is emphasized, which in the current study 
Table 2. Risk factors of CRI — results of univariable linear regression analysis
Infection-related complications OR 95%C P-value
Patient’s age 0.983 0.964–1.002 0.076
Generalized atherosclerosis 3.548 2.043–6.159 0.000
Diabetes 2.579 1.415–4.699 0.002
Venous thrombotic complications 2.274 1.217–4.250 0.010
Neoplastic disease 2.311 1.275–4.189 0.006
Atrial fibrillation 7.917 2.421–25.888 0.001
Arterial hypertension 4.083 2.348–7.103 0.000
Coronary artery disease 7.233 3.688–14.185 0.000
Heart failure 9.411 5.208–17.005 0.000
Co-existing diseases 2.109 1.178–3.777 0.012
The multivariable linear regression analysis has shown that independent risk factors of CRI were: younger age of patients, the presence of coronary artery disease and 
heart failure (Table 3); OR: odds ratio, CI: confidence inteval
Table 3. The risk factors of CRI — results of multivariable linear regression analysis
Infection-related complications OR 95%CI P-value
Patient’s age 0.955 0.931–0.979 0.000
Generalized atherosclerosis 1.859 0.751–4.598 0.178
Diabetes 0.783 0.352–1.745 0.549
Thrombotic complications 1.429 0.661–3.092 0.363
Neoplastic disease 1.556 0.751–3.225 0.233
Co-existing diseases 1.320 0.643–2.710 0.448
Atrial fibrillation 1.923 0.414–8.920 0.402
Arterial hypertension 1.840 0.909–3.725 0.089
Coronary artery disease 3.412 1.423–8.179 0.006
Heart failure 4.532 2.013–10.202 0.000
OR: odds ratio; CI: confidence inteval
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was an important risk factor in univariable analysis. 
A large group of patients dialyzed with permanent 
catheters showed that the risk factors for infectious 
complications were: prior bacteraemia, diabetes 
mellitus, time from catheter implantation > 90 
days, and hypertension [16]. Risk factors identified 
by another report included diabetes, generalized 
atherosclerosis, history of bacteraemia and carrying 
Staphylococcus aureus in the nasal cavity if coupled 
with long-term use of a catheter [13]. Other observa-
tion which involved 102 patients with 42 catheter-
related infections also identified diabetes, a low level 
of albumins and haemoglobin as factors contributing 
to infection-related complications [11]. In turn, 
a recent analysis of early catheter infection found an 
essential role of carrying MRSA (methicillin resistant) 
Staphylococcus aureus, previous catheter-related 
infection and bacteraemia or bacteriuria occurring 
up to 3 months before catheter insertion [1, 6, 13]. 
In most cases, Gram-positive bacteria are responsi-
ble for infection among dialyzed patients: it is reported 
that they caused up to 75% catheter-related infections 
[6, 7, 13, 19, 20], with two pathogens being the most 
frequent: Staphylococcus epidermidis (35%) and Staph-
ylococcus aureus (35%). Gram-negative pathogens 
were found in up to 40% of cases [5, 6, 9, 17, 21, 22]. 
Our results showed similar proportions: 57.35% of 
infections were caused by Gram-positive bacteria, 
including Staphylococcus aureus (29.41%) and other 
Staphylococci (27.94%), mainly by Staphylococcus epi-
dermidis. Infections caused by Gram-negative bacteria 
accounted for 42.64 %.
Blood infection due to vascular access is a serious 
challenge both in terms of diagnosis and therapy, which 
is especially noticeable in intensive care units, where 
it accounts for about 20–40% of all hospital infections 
[22–24]. The current study confirmed a low probability 
of survival of patients with infectious complications 
(53,85%) during the follow-up period, however, it 
was comparable to the high mortality rate of dialyzed 
patients without infection (49.25%; P = 0,588). The 
apparent lack of significant influence of infection on the 
survival of this group of patients is probably associated 
with the strong impact of other known risk factors for 
death in patients with renal failure: premature athero-
sclerosis and associated metabolic disorders.
The mortality rate among dialysis patients depends 
on the type of vascular access and is higher in patients 
with catheters and fistulas made of artificial materials [1, 
4, 17, 22, 24–27]. Paradoxically, progress in medicine 
has led to an increase in infection rate by introducing 
artificial materials to build new vascular access. One 
study which analysed a large population of 2,666 pa-
tients dialyzed by catheters showed 32% mortality rate 
over the period of observation. The study showed that 
patients with tunnelled catheters had 6.9-fold higher 
mortality from sepsis compared to patients dialyzed 
with A-V fistula [28]. The results of our study showed 
that the following factors contributed to the higher risk 
of death: the presence of heart and vessels implants and 
Figure 1. Kaplan Meier time free of death in groups of patients divided depending on dialysis catheter infection presence
The Kaplan-Meier probability of survival of time free from death depending on the occurrence 
of infectious complications, p = 0.312
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Table 5. Factors affecting survival among patients dialyzed through permanent catheters and suffering infection-related complications
Infection-related complications Death Survivors P  
Mann-Withney  
“U”/c2 test
No of patients (n, %) 7 (14.9%) 40 (85.1%) –
Average age (years, SD) 73.579 (6.80) 66.55 (14.41) 0.174
Female patients (n, %) 4 (57.14%) 23 (57.50%) 0.692
Hospitalization time (days, SD) 12.57 (6.63) 13.40 (9.94) 0.756
Time from catheter insertion to infection occurrence (months, SD) 8.62 (8.80) 3.97 (4.21) 0.124
Generalized atherosclerosis (n, %) 7 (100%) 25 (62.50%) 0.128
Diabetes (n, %) 2 (28.57%) 17 (42.50%) 0.783
Thrombotic complications (n, %) 0 (0.00%) 5 (12.50%) 0.745
Infection-related complications over the last 6 months (n, %) 5 (71.43%) 23 (57.50%) 0.783
Neoplastic disease (n, %) 3 (42.86%) 13 (32.50%) 0.919
COPD (n, %) 1 (14.29%) 3 (7.50%) 0.888
Atrial fibrillation (n, %) 3 (42.86%) 5 (12.50%) 0.154
Arterial hypertension (n, %) 6 (85.71%) 29 (72.50%) 0.787
Coronary artery disease (n, %) 5 (71.43%) 18 (37.50%) 0.379
NYHA class I–II (n, %) 2 (28,57%) 22 (55,00%) 0.379
NYHA class III–IV (n, %) 5 (71.43%) 17 (42.50%) 0.315
Stroke (n, %) 0 (0.00%) 4 (10.00%) 0.888
Cardiac implants (n, %) 5 (71.43%) 10 (25.00%) 0.046
Positive catheter culture (n, %) 6 (85.71%) 28 (70.00%) 0.690
Local symptoms of infection (n, %) 1 (14.29%) 15 (37.50%) 0.445
Positive blood culture (n, %) 7 (100%) 38 (95.00%) 0.682
Positive blood culture, Gram-positive bacteria (n, %) 4 (57.14%) 19 (47.50%) 0.951
Positive blood culture, Gram-negative bacteria (n, %) 3 (42.86%) 21 (52.50%) 0.951
Systemic symptoms of infection (n, %) 7 (100%) 36 (90.00%) 0.888
Pneumonia (n, %) 2 (28.57%) 4 (10.00%) 0.457
Infective endocarditis (n, %) 0 (0.00%) 2 (5.00%) 0.682
Hypotension (n, %) 5 (71.43%) 10 (25.00%) 0.046
Patients with recurring infection-related complications (n, %) 1 (14.29%) 12 (30.00%) 0.690
Venous access: right angle (n, %) 2 (28.57%) 25 (62.50%) 0.208
Venous access: left angle (n, %) 2 (28.57%) 7 (17.50%) 0.868
Venous access: left subclavian vein (n, %) 2 (28.57%) 1 (2.50%) 0.078
Venous access: right subclavian vein (n, %) 0 (0.00%) 2 (5.00%) 0.682
Venous access: left femoral vein (n, %) 0 (0.00%) 0 (0.00%) –
Venous access: right femoral vein (n, %) 1 (14.29%) 3 (7.50%) 0.888
Catheter tip location: superior vena cava (n, %) 6 (85.71%) 35 (87.50%) 0.629
Catheter tip location: inferior vena cava (n, %) 1 (14.29%) 4 (10.00%) 0.745
Catheter removal due to infection (n, %) 3 (42.86%) 8 (20.00%) 0.404
Patients with catheter no > 1 0 (0.00%) 4 (10.00%) 0.888
Procalcitonin (ng/mL; av., SD) 29.91 (15.39) 32.00 (70.89) 0.108
CRP (C-reactive protein) (mg/L; av., SD) 2.6 (1.72) 1.38 (1.11) 0.141
Leucocytes (U/L; av., SD) 14.20 (5.23) 10.63 (5.89) 0.056
Haemoglobin (mg/dl; av., SD) 9.31 (1.98) 10.09 (1.44) 0.316
Platelets (K/L; av., SD.) 104 (56) 171 (78) 0.015
Leucocytes/platelets ratio (av., SD) 0.16 (0.09) 0.08 (0.06) 0.002
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; CIED: cardiac implantable electronic devices
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severe infection with hypotension, high leukocytosis, 
thrombocytopenia and a high ratio of leukocytes to 
platelets. Previous reports confirmed an unfavourable 
prognosis for cases of similar constellation of inflamma-
tory parameters in dialyzed patients [11, 13, 29–32]. 
The present study also demonstrated that the 
presence of artificial devices and biomaterials increase 
mortality risk in the course of infection in patients di-
alyzed with permanent catheters (OR = 7.5; 95%CI: 
1.193–47.159; P = 0,027). Likewise, previous reports 
showed a negative effect of the presence of the cardiac 
implantable electronic devices on the development of 
infectious complications. Endocarditis, bacteremia and 
sepsis were often complications observed in this popu-
lation, especially in patients dialyzed with permanent 
catheters [17, 23, 25, 26, 33]. Infectious complications 
caused by a dialysis catheter are a serious problem. 
Although the study was conducted on a small group 
and was retrospective, it showed certain risk factors 
for death and poor prognosis in this burdened group, 
similar to those of other researchers. The situation re-
quires further observation and conducting a prospective 
study, preferably on a larger group of patients, in order 
to obtain better results.
 Study limitations
This study is a retrospective analysis and it was 
conducted on the basis of selected data made available 
by the National Health Fund. Detailed clinical data con-
cerning infection-related complications were available 
for 47 patients only. 
Conclusions 
Infections in patients dialyzed with permanent catheters 
are a common, serious complication. The specific risk 
factors of catheter-related infections include younger 
age, coronary artery disease and heart failure. Mortality 
of patients with infectious complications is very high, 
but comparable to the survival of all dialyzed by the 
permanent catheter. A higher mortality rate among 
patients with catheter-related infection increase with 
the presence of additional intravascular and intracardiac 
implanted materials and a severe course of infection 
with hypotension, thrombocytopenia and a high leu-
cocytes/platelets ratio.
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